Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Rituximab-treated patients have a poor response to influenza vaccination.

Eisenberg RA, Jawad AF, Boyer J, Maurer K, McDonald K, Prak ET, Sullivan KE.

J Clin Immunol. 2013 Feb;33(2):388-96. doi: 10.1007/s10875-012-9813-x. Epub 2012 Oct 14.

2.

Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.

Muller RB, Maier R, Hoschler K, Zambon M, Ludewig B, Herrmann M, Schulze-Koops H, von Kempis J.

Clin Exp Rheumatol. 2013 Sep-Oct;31(5):723-30. Epub 2013 Jun 14.

PMID:
23806224
3.

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.

van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M.

Arthritis Rheum. 2010 Jan;62(1):75-81. doi: 10.1002/art.25033.

4.

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.

Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O.

Vaccine. 2011 Feb 11;29(8):1643-8. doi: 10.1016/j.vaccine.2010.12.072. Epub 2011 Jan 4.

PMID:
21211590
5.

Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.

Bedognetti D, Zoppoli G, Massucco C, Zanardi E, Zupo S, Bruzzone A, Sertoli MR, Balleari E, Racchi O, Messina M, Caltabiano G, Icardi G, Durando P, Marincola FM, Boccardo F, Ferrarini M, Ansaldi F, De Maria A.

J Immunol. 2011 May 15;186(10):6044-55. doi: 10.4049/jimmunol.1004095. Epub 2011 Apr 15.

6.

Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.

Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, Cutler CS, Koreth J, Armand P, Ho VT, Antin JH, Soiffer RJ, Baden LR.

Biol Blood Marrow Transplant. 2011 Mar;17(3):434-8. doi: 10.1016/j.bbmt.2010.10.002. Epub 2010 Oct 13.

7.

Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.

Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.

Ann Rheum Dis. 2008 Jul;67(7):937-41. Epub 2007 Nov 2.

8.

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A.

Arthritis Rheum. 2010 Jan;62(1):64-74. doi: 10.1002/art.25034.

9.

The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.

Berglund A, Willén L, Grödeberg L, Skattum L, Hagberg H, Pauksens K.

Acta Oncol. 2014 Sep;53(9):1212-20. doi: 10.3109/0284186X.2014.914243. Epub 2014 May 28.

PMID:
24865118
10.

Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.

Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M.

Clin Exp Immunol. 2014 Oct;178(1):40-7. doi: 10.1111/cei.12390.

11.

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment.

Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordøy T, Dudman S, Kilander A, Wader KF, Ostenstad B, Ekanger R, Meyer P, Kolstad A.

Blood. 2011 Dec 22;118(26):6769-71. doi: 10.1182/blood-2011-08-372649. Epub 2011 Nov 4.

12.

Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.

Rehnberg M, Brisslert M, Amu S, Zendjanchi K, Håwi G, Bokarewa MI.

Arthritis Res Ther. 2010;12(3):R111. doi: 10.1186/ar3047. Epub 2010 Jun 8.

13.

Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation.

Parmigiani A, Alcaide ML, Freguja R, Pallikkuth S, Frasca D, Fischl MA, Pahwa S.

PLoS One. 2013 Nov 13;8(11):e79816. doi: 10.1371/journal.pone.0079816. eCollection 2013.

14.

Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity.

Salemi S, Picchianti-Diamanti A, Germano V, Donatelli I, Di Martino A, Facchini M, Nisini R, Biselli R, Ferlito C, Podestà E, Cappella A, Milanetti F, Rossi F, Amodeo R, Tabacco F, Di Rosa R, Laganà B, D Amelio R.

Clin Immunol. 2010 Feb;134(2):113-20. doi: 10.1016/j.clim.2009.09.014. Epub 2009 Oct 21.

PMID:
19846344
15.

Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy.

Kroon FP, Rimmelzwaan GF, Roos MT, Osterhaus AD, Hamann D, Miedema F, van Dissel JT.

AIDS. 1998 Dec 3;12(17):F217-23.

PMID:
9863863
16.

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Kapetanovic MC, Kristensen LE, Saxne T, Aktas T, Mörner A, Geborek P.

Arthritis Res Ther. 2014 Jan 2;16(1):R2. doi: 10.1186/ar4427.

17.

Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized study in adults aged 18-60 years and older.

Van Damme P, Kafeja F, Bambure V, Hanon E, Moris P, Roman F, Gillard P.

Hum Vaccin Immunother. 2013 Jul;9(7):1512-22. doi: 10.4161/hv.24504. Epub 2013 Apr 9.

PMID:
23571166
18.
19.

Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.

Hsu JP, Phoon MC, Koh GC, Chen MI, Lee VJ, Wu Y, Xie ML, Cheong A, Leo YS, Chow VT.

Int J Infect Dis. 2012 Aug;16(8):e621-7. doi: 10.1016/j.ijid.2012.04.010. Epub 2012 Jun 15.

20.

Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.

Tesfa D, Ajeganova S, Hägglund H, Sander B, Fadeel B, Hafström I, Palmblad J.

Arthritis Rheum. 2011 Aug;63(8):2209-14. doi: 10.1002/art.30427.

Supplemental Content

Support Center